🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

French health body recommends delaying second COVID shot to six weeks after first

Published 2021-01-23, 06:50 a/m
© Reuters. Coronavirus disease (COVID-19) vaccination in Lamballe-Armor
PFE
-

PARIS (Reuters) - France's top health advisory body on Saturday recommended doubling the time between people being given the first and second COVID-19 vaccinations to six weeks from three in order to increase the number getting inoculated.

The gap between the first and second injection in France is currently three weeks for people in retirement homes, who take priority, and four weeks for others such as health workers.

The Haute Autorite de Sante (HAS) said spacing out the two required vaccinations of the Pfizer/BioNtech and Moderna vaccines would allow the treatment of at least 700,000 more people in the first month.

"The growing number of infections and the worrying arrival of new variants call for an acceleration of the vaccination campaign in order to prevent the epidemic from spiking in coming weeks," the HAS said in a statement.

The HAS said that while there is no agreement between different countries about the optimal timelag between the two shots, it seemed reasonable to delay the second injection to six weeks as the first shot would already provide protection against the coronavirus from the 12th or 14th day after the injection.

It added it was essential for people to get a second injection.

The HAS is an independent advisory body whose recommendations can inspire government policy but don't automatically translate into action.

The World Health Organization said early this month that people should get two doses of the Pfizer/BioNTech vaccine within 21 to 28 days.

Several countries are considering ways to stretch scarce supplies of COVID-19 vaccines, including by delaying dosing intervals or reducing dose sizes.

In Britain, regulators have ruled that shots can be administered up to 12 weeks apart, though a group of British doctors have written to England's chief medical officer to tell him to cut the gap between doses of the Pfizer/BioNTech vaccine to six weeks.

© Reuters. Coronavirus disease (COVID-19) vaccination in Lamballe-Armor

Pfizer (NYSE:PFE) and BioNTech have warned they have no evidence their vaccine would continue to be protective if the second dose is given more than 21 days after the first.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.